Georgetown University is a private research university in the Georgetown neighborhood of Washington, D.C.

During the past decade, Georgetown University conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 58 clinical trials were completed, i.e. on average, 42.3% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 27 clinical trials were completed. i.e. 44.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgetown University" #1 sponsor was "Georgetown University" with 37 trials, followed by "University of Southern California" with 8 trials sponsored, "Gilead Sciences" with 5 trials sponsored, "Merck Sharp & Dohme LLC" with 5 trials sponsored and "Seagen Inc." with 5 trials sponsored. Other sponsors include 170 different institutions and companies that sponsored additional 136 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgetown University" #1 collaborator was "National Institute on Aging (NIA)" with 15 trials as a collaborator, "Georgetown University" with 14 trials as a collaborator, "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 10 trials as a collaborator and "Genentech, Inc." with 10 trials as a collaborator. Other collaborators include 290 different institutions and companies that were collaborators in the rest 183 trials.

According to Clinical.Site data, the most researched conditions in "Georgetown University" are "Breast Cancer" (10 trials), "Alzheimer's Disease" (9 trials), "HIV Infections" (7 trials), "Colorectal Cancer" (6 trials) and "Hepatocellular Carcinoma" (6 trials). Many other conditions were trialed in "Georgetown University" in a lesser frequency.

Most popular intervention types in "Georgetown University" are "Drug" (140 trials), "Other" (26 trials), "Behavioral" (23 trials), "Biological" (16 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Pembrolizumab" (7 trials), "Bevacizumab" (5 trials), "Atezolizumab" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Georgetown University" are 208 trials for "All" genders, 16 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are 80 active trials in "Georgetown University". 3 are not yet recruiting, 52 are recruiting, 23 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 109 completed trials in Georgetown University, 1 suspended trials, and 27 terminated clinical trials to date.

Out of the total trials that were conducted in Georgetown University, 25 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 35 trials that are defined as “Not Applicable".

Georgetown University has several departments that took part in Clinical trials: "Lombardi Comprehensive Cancer Center at Georgetown University Medical Center" - 398 trials, "Georgetown University Hospital - Dept of Neurology" - 9 trials, "Georgetown University Department of Family Medicine" - 7 trials, "Georgetown University Medical Center - Department of Rheumatology" - 5 trials, "Georgetown University; Research Division, Psychiatry" - 3 trials, "Georgetown Children's Research Network" - 2 trials, "Georgetown University Medical Center Department of Pharmacy, Research" - 2 trials, "Clinical Research Unit" - 2 trials, "Georgetown University Medical Center - Division of Infectious Diseases" - 2 trials